Tag: arteriovenous grafts
Comparing AVG material and comparative outcomes needs further examination with promise...
At the most recent American Society of Diagnostic and Interventional Nephrology (ASDIN) annual scientific meeting (23–25 February 2024, New Orleans, USA), Victoria Teodorescu (Emory...
Phraxis presents trial results and extended study data for EndoForce endovascular...
At this year’s VEITHsymposium (14–18 November, New York, USA), Alexander Yevzlin (Azura Surgery Center, Madison, USA) gave a presentation on the EndoForce endovascular...
A raft of new directions for vascular access grafts
A departure from the “extreme mantra” of Fistula First unlocks the door to a new, dynamic vision that could swing the pendulum back to...
Not always ‘the alternative’: Are arteriovenous grafts unfairly maligned?
The arteriovenous graft (AVG) for use as a dialysis conduit is a story of innovation, disappointment, intrigue, politics and hope. A recent recalibration of...
InnAVasc gains FDA nod for third study phase of investigational haemodialysis...
As per an announcement on the company’s LinkedIn page, InnAVasc Medical has been granted US Food and Drug Administration (FDA) permission to commence the...
Xeltis initiates European first-in-human trial of restorative haemodialysis access graft
Xeltis has announced initiation of a clinical trial evaluating Axess, which it claims is the first ever restorative synthetic haemodialysis access graft. Several patients...
Bright future for access grafts highlighted at VASBI 2021 with multiple...
New technologies intended to improve the often-mixed outcomes associated with arteriovenous grafts (AVGs) for haemodialysis access were on display at this year’s Vascular Access...
Early-cannulation grafts display parity with ePTFE options—but also face similar challenges
In addition to demonstrating comparable performance in terms of long-term patency, durability and associated complications, early-cannulation arteriovenous (AV) grafts may hold some advantages when...